AngioDynamics Inc. (NASDAQ: ANGO) reported first quarter 2021 earnings results today.
Net sales increased 6.3% to $70.2 million but were impacted by the disruption to procedure volumes due to the COVID-19 pandemic.
The company recorded a net loss of $4.3 million, or $0.11 per share, compared to a net loss of approx. $1.3 million, or $0.03 per share, a year ago. Adjusted net income was $0.6 million, or $0.02 per share.
AngioDynamics expects fiscal year 2021 net sales to be in the range of $278-284 million and adjusted EPS to be $0.00 to $0.05.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Visa Inc. (NYSE: V) reported first quarter 2023 earnings results today. Net revenues grew 12% year-over-year to $7.9 billion. GAAP net income rose 6% to $4.2 billion while EPS grew
Intel Corporation (NASDAQ: INTC) Thursday reported a decline in adjusted earnings and revenues for the fourth quarter. The semiconductor giant also provided guidance for the first quarter of 2023. Fourth-quarter
Shares of McCormick & Company Inc. (NYSE: MKC) were down over 5% on Thursday after the company missed expectations on its fourth quarter 2022 results and provided a lower-than-expected earnings